BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27756618)

  • 1. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo.
    Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
    Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.
    Tong Y; Huang H; Pan H
    Biochem Biophys Res Commun; 2015 Jan; 456(1):86-91. PubMed ID: 25446102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy inhibition sensitizes KU-0063794-mediated anti-HepG2 hepatocellular carcinoma cell activity in vitro and in vivo.
    Yongxi T; Haijun H; Jiaping Z; Guoliang S; Hongying P
    Biochem Biophys Res Commun; 2015 Sep; 465(3):494-500. PubMed ID: 26278819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
    Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
    Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage.
    Mao Z; Han X; Chen D; Xu Y; Xu L; Yin L; Sun H; Qi Y; Fang L; Liu K; Peng J
    Br J Pharmacol; 2019 Apr; 176(7):919-937. PubMed ID: 30710454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
    Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
    Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
    Correa RJ; Valdes YR; Peart TM; Fazio EN; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Carcinogenesis; 2014 Sep; 35(9):1951-61. PubMed ID: 24562574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms.
    Chen MB; Zhou ZT; Yang L; Wei MX; Tang M; Ruan TY; Xu JY; Zhou XZ; Chen G; Lu PH
    Oncotarget; 2016 Mar; 7(13):17047-59. PubMed ID: 26933997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.
    Kim MN; Lee SM; Kim JS; Hwang SG
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.
    Zhai B; Hu F; Jiang X; Xu J; Zhao D; Liu B; Pan S; Dong X; Tan G; Wei Z; Qiao H; Jiang H; Sun X
    Mol Cancer Ther; 2014 Jun; 13(6):1589-98. PubMed ID: 24705351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway.
    Sun R; Zhai R; Ma C; Miao W
    Cancer Med; 2020 Feb; 9(3):1141-1151. PubMed ID: 31830378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways.
    Yan Y; Jiang K; Liu P; Zhang X; Dong X; Gao J; Liu Q; Barr MP; Zhang Q; Hou X; Meng S; Gong P
    Sci Rep; 2016 Nov; 6():37052. PubMed ID: 27845389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy.
    Zhang G; Wang Z; Chen W; Cao Y; Wu J; Qiang G; Ji A; Wu J; Jiang C
    Int J Biochem Cell Biol; 2019 Aug; 113():48-57. PubMed ID: 31128260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
    Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
    Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
    Wang Y; Han C; Lu L; Magliato S; Wu T
    Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells.
    Tsai SC; Yang JS; Peng SF; Lu CC; Chiang JH; Chung JG; Lin MW; Lin JK; Amagaya S; Wai-Shan Chung C; Tung TT; Huang WW; Tseng MT
    Int J Oncol; 2012 Oct; 41(4):1431-42. PubMed ID: 22858649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypyridinone-Coumarin Inhibits the Proliferation of MHCC97 and HepG2 Human Hepatocellular Carcinoma Cells and Down-Regulates the Phosphoinositide-3 Kinase Pathway.
    Cui X; Qin X
    Med Sci Monit; 2020 Mar; 26():e920785. PubMed ID: 32218414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.